Poloxamer 331 April 12, 2017 Poloxamer 331 Trade Name Protox Orphan Indication Initial therapy of toxoplasmosis in patients with AIDS USA Market Approval USA USA Designation Date 1991-03-21 00:00:00 Sponsor CytRx Corporation;154 Technology Parkway;Norcross, Georgia, 30092
